» Articles » PMID: 28842672

Downregulation of PARP1 Transcription by Promoter-associated E2F4-RBL2-HDAC1-BRM Complex Contributes to Repression of Pluripotency Stem Cell Factors in Human Monocytes

Overview
Journal Sci Rep
Specialty Science
Date 2017 Aug 27
PMID 28842672
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Differentiation of certain cell types is followed by a downregulation of PARP1 expression. We show that the reduction in the abundance of PARP1 in hematopoietic progenitor cells and monocytes is tightly controlled by the cell cycle. The differentiation-associated cell cycle exit induces E2F1 replacement with E2F4 at the PARP1 promoter and the assembly of an E2F4-RBL2-HDAC1-BRM(SWI/SNF) repressor complex which deacetylates nucleosomes and compacts chromatin. In G1 arrested cells, PARP1 transcription is reduced by the recruitment of E2F1-RB1-HDAC1-EZH2(PRC2)-BRM/BRG1(SWI/SNF), which additionally trimethylates H3K27 and causes an even higher increase in nucleosome density. The re-establishment of an active chromatin structure by treating post-mitotic monocytes with the HDAC inhibitor and G1 arrested cells with a combination of HDAC and EZH2 inhibitors restores PARP1 expression completely but does not affect the interaction between the components of the repressor complex with chromatin. This suggests that RB1 and RBL2, as well as PRC2, SWI/SNF and HDAC1, do not interfere with the transcription machinery. Interestingly, reinstatement of PARP1 expression by the silencing of RBL2 or by the inhibition of HDACs in monocytes and by transfection with the PARP1 expression vector in differentiated THP-1 cells substantially increased transcription of pluripotency stem cell factors such as POU5F1, SOX2 and NANOG.

Citing Articles

Nicotinamide Mononucleotide Is Safely Metabolized and Significantly Reduces Blood Triglyceride Levels in Healthy Individuals.

Kimura S, Ichikawa M, Sugawara S, Katagiri T, Hirasawa Y, Ishikawa T Cureus. 2022; 14(9):e28812.

PMID: 36225528 PMC: 9534732. DOI: 10.7759/cureus.28812.


Differential Expression of Zinc-Dependent HDAC Subtypes and their Involvement in Unique Pathways Associated with Carcinogenesis.

Ukey S, Ramteke A, Choudhury C, Purohit P, Sharma P Asian Pac J Cancer Prev. 2022; 23(3):877-883.

PMID: 35345359 PMC: 9360949. DOI: 10.31557/APJCP.2022.23.3.877.


CBP/p300 Bromodomain Inhibitor-I-CBP112 Declines Transcription of the Key ABC Transporters and Sensitizes Cancer Cells to Chemotherapy Drugs.

Strachowska M, Gronkowska K, Michlewska S, Robaszkiewicz A Cancers (Basel). 2021; 13(18).

PMID: 34572840 PMC: 8467251. DOI: 10.3390/cancers13184614.


LSD1 Facilitates Pro-Inflammatory Polarization of Macrophages by Repressing Catalase.

Sobczak M, Strachowska M, Gronkowska K, Karwaciak I, Pulaski L, Robaszkiewicz A Cells. 2021; 10(9).

PMID: 34572113 PMC: 8469135. DOI: 10.3390/cells10092465.


MyoD induces ARTD1 and nucleoplasmic poly-ADP-ribosylation during fibroblast to myoblast transdifferentiation.

Bisceglie L, Hopp A, Gunasekera K, Wright R, Le Dily F, Vidal E iScience. 2021; 24(5):102432.

PMID: 33997706 PMC: 8102911. DOI: 10.1016/j.isci.2021.102432.


References
1.
Tang L, Nogales E, Ciferri C . Structure and function of SWI/SNF chromatin remodeling complexes and mechanistic implications for transcription. Prog Biophys Mol Biol. 2010; 102(2-3):122-8. PMC: 2924208. DOI: 10.1016/j.pbiomolbio.2010.05.001. View

2.
Rosado M, Bennici E, Novelli F, Pioli C . Beyond DNA repair, the immunological role of PARP-1 and its siblings. Immunology. 2013; 139(4):428-37. PMC: 3719060. DOI: 10.1111/imm.12099. View

3.
Young M, Willson T, Wakefield M, Trounson E, Hilton D, Blewitt M . ChIP-seq analysis reveals distinct H3K27me3 profiles that correlate with transcriptional activity. Nucleic Acids Res. 2011; 39(17):7415-27. PMC: 3177187. DOI: 10.1093/nar/gkr416. View

4.
Aly A, Ganesan S . BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability. J Mol Cell Biol. 2011; 3(1):66-74. PMC: 3030974. DOI: 10.1093/jmcb/mjq055. View

5.
Schiewer M, Knudsen K . Transcriptional roles of PARP1 in cancer. Mol Cancer Res. 2014; 12(8):1069-80. PMC: 4134958. DOI: 10.1158/1541-7786.MCR-13-0672. View